0001595215-16-000004.txt : 20161005 0001595215-16-000004.hdr.sgml : 20161005 20161005125334 ACCESSION NUMBER: 0001595215-16-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161005 DATE AS OF CHANGE: 20161005 EFFECTIVENESS DATE: 20161005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspyrian Therapeutics, Inc. CENTRAL INDEX KEY: 0001595215 IRS NUMBER: 272624716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-258981 FILM NUMBER: 161921859 BUSINESS ADDRESS: STREET 1: 10581 ROSELLE STREET, SUITE 115 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-925-5619 MAIL ADDRESS: STREET 1: 10581 ROSELLE STREET, SUITE 115 CITY: SAN DIEGO STATE: CA ZIP: 92121 D/A 1 primary_doc.xml X0707 D/A LIVE 0001595215 Aspyrian Therapeutics, Inc. 10581 ROSELLE STREET, SUITE 115 SAN DIEGO CA CALIFORNIA 92121 858-925-5619 DELAWARE None None Corporation true Miguel Garcia-Guzman 10581 Roselle Street, Suite 115 San Diego CA CALIFORNIA 92121 Executive Officer Director Merrill Biel 10581 Roselle Street, Suite 115 San Diego CA CALIFORNIA 92121 Executive Officer Director Hiroshi Mikitani 10581 Roselle Street, Suite 115 San Diego CA CALIFORNIA 92121 Director Hiroshi Mori 10581 Roselle Street, Suite 115 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b true 0001595215-16-000002 2016-02-24 false true false 0 56049999 55199998 850001 false 8 0 0 0 false Aspyrian Therapeutics, Inc. /s/ Miguel Garcia-Guzman Miguel Garcia-Guzman Chief Executive Officer 2016-10-05